Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, Lebanon.
Pillar Genomics Institute of Precision Medicine, American University of Beirut, Beirut, Lebanon.
Clin Genet. 2020 Aug;98(2):116-125. doi: 10.1111/cge.13767. Epub 2020 Jun 29.
Discoid lupus erythematosus (DLE) is an autoimmune disorder with a poorly defined etiology. Despite epidemiologic gender and ethnic biases, a clear genetic basis for DLE remains elusive. In this study, we used exome and RNA sequencing technologies to characterize a consanguineous Lebanese family with four affected individuals who presented with classical scalp DLE and generalized folliculitis. Our results unraveled a novel biallelic variant c.1313C > A leading to a missense substitution p.(Thr438Asn) in TRAF3IP2(NM_147200.3). Expression studies in cultured cells revealed mis-localization of the mutated protein. Functional characterization of the mutated protein showed significant reduction in the physical interaction with the interleukin 17-A receptor (IL17RA), while interaction with TRAF6 was unaffected. By conducting a differential genome-wide transcriptomics analysis between affected and non-affected individuals, we showed that the hair follicle differentiation pathway is drastically suppressed, whereas cytokine and inflammation responses are significantly upregulated. Furthermore, our results were highly concordant with molecular signatures in patients with DLE from a public dataset. In conclusion, this is the first report on a new putative role for TRAF3IP2 in the etiology of DLE. The identified molecular features associated with this gene could pave the way for better DLE-targeted treatment.
盘状红斑狼疮(DLE)是一种病因不明的自身免疫性疾病。尽管存在流行病学性别和种族偏见,但 DLE 的明确遗传基础仍然难以捉摸。在这项研究中,我们使用外显子组和 RNA 测序技术来描述一个有亲缘关系的黎巴嫩家庭,该家庭有四个受影响的个体,他们表现为典型的头皮 DLE 和全身性滤泡炎。我们的研究结果揭示了一种新的纯合变异 c.1313C > A 导致 TRAF3IP2(NM_147200.3)中的错义取代 p.(Thr438Asn)。在培养的细胞中进行的表达研究显示突变蛋白的错误定位。对突变蛋白的功能特征进行了研究,发现其与白细胞介素 17-A 受体(IL17RA)的物理相互作用显著减少,而与 TRAF6 的相互作用不受影响。通过对受影响和未受影响个体进行差异全基因组转录组学分析,我们显示毛囊分化途径明显受到抑制,而细胞因子和炎症反应显著上调。此外,我们的结果与公共数据集来自 DLE 患者的分子特征高度一致。总之,这是首次报道 TRAF3IP2 在 DLE 发病机制中的新作用。与该基因相关的鉴定分子特征可能为更好的 DLE 靶向治疗铺平道路。